Enzymotec is pleased to announce the opening of a subsidiary
in the United States. The new company will manage its ongoing sales and
enable better service to its accounts.
The company, located in the United States, will be managed by
Elzaphan Hotam, previously Enzymotec's vice president of business
development.
Enzymotec is an Israeli biotech company that develops and produces
novel, lipid-based health ingredients for dietary supplements and
functional foods.
The company's leading products are: SharpPS and
SharpPS GOLD for cognitive performance improvement of seniors,
CardiaBeat offering a broad health effect to reduce CVD risks and InFat
for balanced nutrition in infant formula.
Israel
